@charlie_lees Likely no one, as the ROI does not work. Very expensive HTH trials, large sample sizes, small differences, & no one cares about the results... Money that could probably be better spent elsewhere. Lots of pretty good meds, without big differences in efficacy from each other.

Running into a lifelong friend 🇪🇬 after many years 🔥 Matching colors #ddw2024 #GITtwitter #Friends

A meeting of @IBDHopkins @HopkinsGIHep current and future fellows and faculty!

@JonnyBlackwell Not sure 🤔 Jonny - the SEQUENCE study is good but the data today and the analysis is open to question IMHO On a broader point surprised that post hoc analysis in a plenary session

I am deligthed to host @IBD_FloMD for the @HopkinsGIHep Grand Rounds this week! We are looking forward to learning about end points in clinical trials for fibrosis in IBD, as well as relevant mechanisms in fibrosis and how to target them. A hot area of investigation! @IBDHopkins

Pleased to share our newly published manuscript “PSMA-Targeted PET [18F]DCFPyL as Biomarker in IBD”| CEG @DovePress https://t.co/IBIob0oKLD @FlorinSelaruMD @SSharma___

@AmCollegeGastro @uabmedicine from #Alabama to #Vancouver #UABGI @ladonnaap @SanchezLunaMD present at #ACG2023 what a great experience!

Impromptu mentorship session with #AdvancedEndo #Gurus ⭐️⭐️@EndoscopyOthman & @raman_muthusamy ⭐️⭐️ with trainees and faculty #ACG2023 @bcm_gihep @UTSWGastroHep @WUGastro @UMN_GI @UCLAHealth

Thanks to everyone who volunteered, spoke, and came out to our CCF AL/NW FL Patient Education Day yesterday! Great talks, great questions, and great turnout! @rhhollis @msalehsv

Radiological‐histopathological discordance in patients transplanted for HCC -  based on radiological imaging features alone results in underestimation of HCC burden in one out of three patients with HCC. @msalehsv @PrasunJalal @KanwalFasiha

@KrugCleveland @msalehsv @UChicagoIBD @IBDMD @BowelUltrasound @UChicago @UChicagoGI @DrMikeDolinger @malloc_doc @novakkerri @iuschris So proud @msalehsv ! @HopkinsGIHep @IBDHopkins

It was a pleasure having @msalehsv for module 2 training @UChicagoIBD. #IBD patients in Alabama, you now have a local expert in intestinal ultrasound #UniversityofAlabama

Great to meet some of our Clinical Trialist Boot Camp participants. Thanks cohort 1️⃣, and welcome cohort 2️⃣! #CCCongress23

Votes 4 readers choice best FG article 2022 starts soon- read the blog to see the finalists! #fgcup2022 @DrJamieC @Rutter_Matt @DCharabaty @msalehsv @kevinjmonahan @DrPebsEdwards @imacpherson90 @stumcp @adyeoman @DrMohidKhan @gastrolivuni @c_lam78 @gehanjali @simongabe @GastroNW

Absolutely💃🏻 our review on #Crohns #Stricture Management is the ✅ Editor pick in this issue @FrontGastro_BMJ Along w ⭐️#WomenInGI 🇬🇧Trainees Experience @HelenSteed1 ⭐️UST in refractory UC ⭐️Calpro marker of #PSC? ⭐️Co-morbidities & 1stLine biologic 🔗 https://t.co/AHYWkqcXSC

Read this great review discussing the management of Crohn's strictures from @DCharabaty and @msalehsv - publications to impact practice @RMBeattie50 @BritSocGastro https://t.co/gxdVKIQA7E

Impedance Planimetry for Crohn's Disease Anastomotic Stricture Characterization: A Predictor of Treatment Response? Ismail, et al. 👉 https://t.co/Hytp6fCwzT https://t.co/wPR5blFCho #GItwitter #GIfellows @KatieFalloonMD @TrieuMD @msalehsv @V_Akshintala @VKumbhari @fselaru1

I was very pleased and excited to work on this idea with Dr Selaru and Dr Kumbhari. It is very interesting and innovative to characterize Crohn’s disease strictures with EndoFlip @fselaru1 @VKumbhari @IBDHopkins

🆓#COVID-19 and outcomes in patients with inflammatory bowel disease: Systematic review and meta-analysis 🔶Tripathi K Brewer GG Nguyen MT Singh Y @msalehsv Sauk J @alyssaparian @berkeleydoc (#UCLAGI) 🔶Published @IBDJournals 🔶 https://t.co/A4KPYVCwjV #GITwitter #IBD

We are so grateful for our fellows, and tributes like this make us a little misty eyed. @IBDHopkins